HEART FAILURE WITH REDUCED EJECTION FRACTION
Clinical trials for HEART FAILURE WITH REDUCED EJECTION FRACTION explained in plain language.
Never miss a new study
Get alerted when new HEART FAILURE WITH REDUCED EJECTION FRACTION trials appear
Sign up with your email to follow new studies for HEART FAILURE WITH REDUCED EJECTION FRACTION, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New heart procedure aims to cut hospital visits
Disease control Not yet recruitingThis study is testing a catheter-based procedure called pulmonary artery denervation (PADN) for people with heart failure and high blood pressure in their lungs. It aims to see if adding this procedure to standard heart failure medications is safer and more effective at preventin…
Matched conditions: HEART FAILURE WITH REDUCED EJECTION FRACTION
Phase: NA • Sponsor: Pulnovo Medical, Inc. • Aim: Disease control
Last updated Apr 03, 2026 14:41 UTC
-
Novartis tests new heart pill in small safety trial
Disease control Not yet recruitingThis early-stage study aims to check the safety and measure how the body processes a new experimental drug called HJB647 for people with chronic heart failure. It will involve about 12 participants who will receive the drug or a placebo for three days while staying in a clinic fo…
Matched conditions: HEART FAILURE WITH REDUCED EJECTION FRACTION
Phase: PHASE1 • Sponsor: Novartis Pharmaceuticals • Aim: Disease control
Last updated Apr 02, 2026 14:58 UTC
-
Stent procedure put to the test for failing hearts
Disease control Not yet recruitingThis study aims to see if a common artery-opening procedure (using a stent) combined with standard heart failure medications works better than the medications alone for people with a weak heart pump caused by clogged heart arteries. It will enroll about 650 adults who have heart …
Matched conditions: HEART FAILURE WITH REDUCED EJECTION FRACTION
Phase: NA • Sponsor: Nanjing First Hospital, Nanjing Medical University • Aim: Disease control
Last updated Mar 30, 2026 14:35 UTC
-
New 'Breathing Pacemaker' aims to ease heart failure burden
Disease control Not yet recruitingThis study is testing a new implanted device called the VisONE System. It aims to see if gently stimulating the diaphragm (the main breathing muscle) in sync with the heartbeat can improve heart function, walking ability, and quality of life for people with a specific type of hea…
Matched conditions: HEART FAILURE WITH REDUCED EJECTION FRACTION
Phase: NA • Sponsor: VisCardia Inc. • Aim: Disease control
Last updated Mar 30, 2026 14:34 UTC
-
App aims to keep heart failure patients out of hospital
Disease control Not yet recruitingThis study is testing whether a digital care platform can help people with a weakened heart pump (heart failure) stay healthier after leaving the hospital. About 774 patients will either use an app to report daily symptoms and vital signs, which helps doctors adjust medications, …
Matched conditions: HEART FAILURE WITH REDUCED EJECTION FRACTION
Phase: NA • Sponsor: Chang sheng Ma • Aim: Disease control
Last updated Mar 30, 2026 14:31 UTC
-
Heart failure breakthrough? major trial tests if catheter procedures beat pills for AFib
Disease control Not yet recruitingThis trial aims to find the best way to manage atrial fibrillation (AFib) in people who also have heart failure. It will compare two main approaches: using catheter-based procedures to restore normal heart rhythm versus using medications and devices to control the heart rate. The…
Matched conditions: HEART FAILURE WITH REDUCED EJECTION FRACTION
Phase: PHASE4 • Sponsor: University of British Columbia • Aim: Disease control
Last updated Mar 30, 2026 14:28 UTC